News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Markets were quiet this hour, major indices little changed and trading volume low.
  • U.S. Treasury yields held steady with no significant moves after an absence of economic releases.
  • Oil and broad commodity prices remained flat without new supply or demand drivers.
  • No central bank statements or policy updates were released in the past hour.
  • No major geopolitical incidents or sudden global events were reported this hour.
  • Corporate newsflow was thin with no material earnings, guidance revisions, or M&A announcements.

Latest Articles

KeyBanc Outlines Three Forces That Could Spur More Software M&A

KeyBanc Outlines Three Forces That Could Spur More Software M&A

KeyBanc Capital Markets says the reported interest from Silver Lake in Workday highlights three dynamics that could prompt increased merger-and-acquisition activity in application software: a shift to consumption pricing, mixed signals on growth durability, and depressed valuations across the sector.

Genasys Sees Share Lift After $1.4M LRAD Orders from APAC and Europe

Genasys Sees Share Lift After $1.4M LRAD Orders from APAC and Europe

Genasys Inc. (NASDAQ:GNSS) experienced a 3% premarket rise after announcing roughly $1.4 million in orders for its Long Range Acoustic Devices (LRAD) from countries in the Asia-Pacific region and Europe. The purchases, which include new and follow-on orders, will support Navy, Coast Guard, police and security operations and are part of sustained in…

Texas Stock Exchange Named Primary Venue for Two TCBI ETFs

Texas Stock Exchange Named Primary Venue for Two TCBI ETFs

Texas Capital Bancshares said two of its exchange-traded funds will designate the Texas Stock Exchange as their primary trading venue beginning September 16, subject to required regulatory approvals. The funds currently trade on NYSE Arca, and their tickers and investment strategies will remain unchanged.

Fabric.AI and Kopin Launch Joint Steering Committee Led by Kopin CEO Michael Murray as Neural I/o™ Industry Engagement Expands

Fabric.AI and Kopin Launch Joint Steering Committee Led by Kopin CEO Michael Murray as Neural I/o™ Industry Engagement Expands

Fabric.AI and Kopin Corporation have established a Joint Steering Committee led by Kopin CEO Michael Murray to oversee development and commercialization of their Neural I/o MicroLED-based optical interconnect platform. The companies are expanding industry engagement, including partnerships within NVIDIA’s NVLink ecosystem, aiming for a live public …

BioMarin’s Shares Jump After Cash-Funded Deal for Alesta’s Oral Asset

BioMarin’s Shares Jump After Cash-Funded Deal for Alesta’s Oral Asset

BioMarin Pharmaceutical shares rose sharply in pre-market trading following a definitive agreement to buy Alesta Therapeutics. The cash-funded deal includes $275 million upfront plus up to $215 million in development and regulatory milestone payments for ALE1, an oral small molecule in Phase 1/2a targeting hypophosphatasia. Two Wall Street firms ra…

Dilution Fears Drive Ondas Shares Lower After Aran Defense Deal

Dilution Fears Drive Ondas Shares Lower After Aran Defense Deal

Ondas shares fell in pre-market trading after the company disclosed a binding agreement to buy Aran Defense Ltd. for roughly $33 million, payable in cash or Ondas stock. Investors reacted to the acquisition's potential for additional share issuance against a backdrop of recent mixed quarterly results, previous heavy selling by a major investor, ele…

China's Data Strategy Could Strengthen Its Edge in AI, U.S. Advisory Panel Says

China's Data Strategy Could Strengthen Its Edge in AI, U.S. Advisory Panel Says

A U.S. congressional advisory commission warned that China is treating data as a strategic national asset and is systematically commercializing and standardizing it to accelerate AI development. The report highlights China's collection of non-scrapable domestic data, expanded regulatory framework, and industry-level data exchanges as potential adva…

Inspired Announces General Counsel Transition

Inspired Announces General Counsel Transition

Inspired Entertainment, Inc., a leading B2B gaming content and technology provider, announced the resignation of General Counsel Simona Camilleri and the promotion of Corporate Secretary Carys Damon to Executive Vice President, General Counsel, and Board Secretary effective September 7, 2026. The company highlights Damon's extensive experience and …

Ondas to Buy Aran Defense for $33M; Shares Dip in Premarket Trading

Ondas to Buy Aran Defense for $33M; Shares Dip in Premarket Trading

Ondas Holdings agreed to acquire Aran Defense Ltd. for approximately $33 million in cash or Ondas stock, a transaction that values Aran Defense at about 1.3 times its projected 2026 revenue. The deal, which aims to bolster Ondas’ Israeli engineering and production footprint for its autonomous defense businesses, sent Ondas shares down 4.9% in prema…

Insider Moves Monday: Large Buys at Apollomics and Cardinal; Major Sales at Dyne, Butterfly, Kinetik and PBF

Insider Moves Monday: Large Buys at Apollomics and Cardinal; Major Sales at Dyne, Butterfly, Kinetik and PBF

Monday’s disclosures show concentrated insider buying at Apollomics Inc. and Cardinal Infrastructure Group Inc., while several sizable sales were reported at Dyne Therapeutics, Butterfly Network, Kinetik Holdings and PBF Energy. The purchases at Apollomics and multiple buys by Cardinal insiders occurred on August 14, 2026, and included private plac…

BioMarin to Buy Alesta for $275M Upfront, Gaining Oral HPP Candidate ALE1

BioMarin to Buy Alesta for $275M Upfront, Gaining Oral HPP Candidate ALE1

BioMarin Pharmaceutical announced an agreement to acquire Alesta Therapeutics for $275 million in upfront cash, securing rights to ALE1, an orally active small molecule in Phase 1/2a testing for hypophosphatasia (HPP). The acquisition includes up to $215 million in milestone payments and will be funded from BioMarin's cash on hand. The transaction …